IL-12 acts selectively on CD8α- dendritic cells to enhance presentation of a tumor peptide in vivo

Journal of Immunology

Volumn 163, Issue 6, 1999, Pages 3100-3105

  Grohmann, Ursula ^a   Blanchi, Roberta ^a   Belladonna, Maria L ^a   Vacca, Carmine ^a   Silla, Silvia ^a   Ayroldi, Emira ^a   Fioretti, Maria C ^a   Puccetti, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD8; ANTIGENS, NEOPLASM; CLONAL ANERGY; DENDRITIC CELLS; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; INJECTIONS, INTRAVENOUS; INTERLEUKIN-10; INTERLEUKIN-12; MALE; MICE; MICE, INBRED DBA; OLIGOPEPTIDES; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 0033567999     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Vremec, D., M. Zorbas, R. Scollay, D. J. Saunders, C. F. Ardavin, L. Wu, and K. Shortman. 1992. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176:47.
3. Süss, G., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183:1789.
4. Kronin, V., K. Winkel, G. Süss, A. Kelso, W. Heath, J. Kirberg, H. von Boehmer, and K. Shortman. 1996. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J. Immunol. 157:3819.
5. - dendritic cells. Eur. J. Immunol. 27:3350.
6. Blanchi, R., U. Grohmann, M. L. Belladonna, S. Silla, F. Fallarino, E. Ayroldi, M. C. Fioretti, and P. Puccetti. 1996. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells. J. Immunol. 157:1589.
7. Grohmann, U., R. Blanchi, E. Ayroldi, M. L. Belladonna, D. Surace, M. C. Fioretti, and P. Puccetti. 1997. A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state. J. Immunol. 158:3593.
8. + lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. Crit. Rev. Immunol. 18:87.
9. Grohmann, U., M. L. Belladonna, R. Bianchi, C. Orabona, E. Ayroldi, M. C. Fioretti, and P. Puccetti. 1998. IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production. Immunity 9:315.
10. + dendritic cells. Immunity 9:839.
11. + T cell reactivity. Eur. J. Immunol. 24:1446.
12. - or helper peptides in priming for skin test reactivity to a P815AB-related peptide, Eur. J. Immunol. 25:2797.
13. Hart, D. N. J. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245.
14. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cells to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444.
15. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
16. Grohmann, U., S. Silla, M. L. Belladonna, R. Bianchi, C. Orabona, P. Puccetti, and M. C. Fioretti. 1997. Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. Cell. Immunol. 181: 109.
17. Ardavin, C., L. Wu, C.-L. Li, and K. Shortman. 1993. Thymic dendritic cells and T cells develop simultaneously within the thymus from a common precursor population. Nature 362:761.
18. Wu, L., D. Vremec, C. Ardavin, K. Winkel, G. Süss, G. Georgiou, E. Maraskovsky, W. Cook, and K. Shortman. 1995. Mouse thymus dendritic cells: kinetics of development and changes in surface markers during maturation. Eur. J. Immunol. 25:418.
19. Wu, L., C.-L. Li, and K. Shortman. 1996. Thymic dendritic cell precursors: relationship to the T-lymphocyte lineage and phenotype of the dendritic cell progeny. J. Exp. Med. 184:903.
20. Maraskowsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in mice treated with Flt3 ligand: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
21. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159:565.
22. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF α. J. Exp. Med. 184:695.
23. Vremec, D., G. J. Lieschke, A. R. Dunn, L. Robb, D. Metcalf, and K. Shortman. 1997. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 27:40.
24. Saunders, D., K. Lucas, J. Ismaili, L. Wu, E. Maraskovsky, A. Dunn, D. Metcalf, and K. Shortman. 1996. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte-macrophage colony-stimulating factor. J. Exp. Med. 184:2185.
25. Uyttenhove, C., J. Maryansky, and T. Boon. 1983. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J. Exp. Med. 157:1040.
26. Burkly, L., C. Hession, L. Ogata, C. Reilly, L. A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373:531.
27. Pettit, A. R., C. Quinn, K. P. A. MacDonald, L. L. Cavanagh, G. Thomas, W. Townsend, M. Handel, and R. Thomas. 1997. Nuclear localization of relB is associated with effective antigen-presenting cell function. J. Immunol. 159:3681.
28. de Waal Malefyt, R. W., H. Yssel, M. G. Roncarolo, H. Spits, and J. E. de Fries. 1992. Interleukin-10. Curr. Opin. Immunol. 4:314.
29. Steinbrink, K., M. Wölfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772.
30. + T cells. J. Immunol. 154:5071.
31. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kämpgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by murine dendritic cells: up-regulation via MHC class II and CD40 molecules and down-regulation by IL-4 and IL-10. J. Exp. Med. 184:741.
32. Hsu, D. H., K. W. Oore, and H. Spits. 1992. Differential effects of interleukin-4 and -10 on interleukin-2-induced interferon-γ synthesis and lymphokine-activated killer activity. Int. Immunol. 4:563.
33. + T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
34. Trinchieri, G. 1995. Interleukin-12: a proinflammalory cytokine with immunoregulatory functions that bridges innate resistance and antiger. specific adaptive immunity. Annu. Rev. Immunol. 13:251.